Bioprinting-Enabled Biomaterials: A Cutting-Edge Strategy for Future Osteoarthritis Therapy.
biomaterials
bioprinting
drug delivery
osteoarthritis
translation
Journal
International journal of nanomedicine
ISSN: 1178-2013
Titre abrégé: Int J Nanomedicine
Pays: New Zealand
ID NLM: 101263847
Informations de publication
Date de publication:
2023
2023
Historique:
received:
26
07
2023
accepted:
17
10
2023
medline:
8
11
2023
pubmed:
7
11
2023
entrez:
7
11
2023
Statut:
epublish
Résumé
Bioprinting is an advanced technology that allows for the precise placement of cells and biomaterials in a controlled manner, making significant contributions in regenerative medicine. Notably, bioprinting-enabled biomaterials have found extensive application as drug delivery systems (DDS) in the treatment of osteoarthritis (OA). Despite the widespread utilization of these biomaterials, there has been limited comprehensive research summarizing the recent advances in this area. Therefore, this review aims to explore the noteworthy developments and challenges associated with utilizing bioprinting-enabled biomaterials as effective DDS for the treatment of OA. To begin, we provide an overview of the complex pathophysiology of OA, highlighting the shortcomings of current treatment modalities. Following this, we conduct a detailed examination of various bioprinting technologies and discuss the wide range of biomaterials employed in DDS applications for OA therapy. Finally, by placing emphasis on their transformative potential, we discuss the incorporation of crucial cellular components such as chondrocytes and mesenchymal stem cells into bioprinted constructs, which play a pivotal role in promoting tissue regeneration and repair.
Identifiants
pubmed: 37933298
doi: 10.2147/IJN.S432468
pii: 432468
pmc: PMC10625743
doi:
Substances chimiques
Biocompatible Materials
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
6213-6232Informations de copyright
© 2023 Yang et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Bioact Mater. 2022 Jan 29;17:178-194
pubmed: 35386443
Bone. 2023 Jun;171:116746
pubmed: 36965655
Biomater Res. 2016 May 04;20:10
pubmed: 27148455
Adv Biochem Eng Biotechnol. 2020;171:279-319
pubmed: 31468094
Tissue Eng Part C Methods. 2020 Jun;26(6):306-316
pubmed: 32349648
Nanotechnology. 2018 May 4;29(18):185101
pubmed: 29446757
Nat Protoc. 2021 Dec;16(12):5484-5532
pubmed: 34716451
Adv Drug Deliv Rev. 2021 Jul;174:504-534
pubmed: 33991588
J Funct Biomater. 2022 Sep 24;13(4):
pubmed: 36278631
Adv Sci (Weinh). 2023 Jul;10(20):e2207334
pubmed: 37162248
Int J Mol Sci. 2021 Apr 12;22(8):
pubmed: 33921417
Acta Biomater. 2017 Jul 15;57:1-25
pubmed: 28088667
Int J Nanomedicine. 2019 Jun 11;14:4333-4351
pubmed: 31354264
J Mater Chem B. 2022 Sep 21;10(36):7030-7044
pubmed: 36043510
Pharmaceuticals (Basel). 2021 Oct 28;14(11):
pubmed: 34832875
Drug Des Devel Ther. 2021 Jul 06;15:2921-2945
pubmed: 34262259
Chem Rev. 2020 Oct 14;120(19):10793-10833
pubmed: 32902959
Med Clin North Am. 2020 Mar;104(2):293-311
pubmed: 32035570
Expert Opin Biol Ther. 2019 Aug;19(8):773-779
pubmed: 31009588
Int J Bioprint. 2022 Apr 22;8(3):511
pubmed: 36105138
Biomed Mater. 2019 Sep 25;14(6):065009
pubmed: 31426033
Nat Biotechnol. 2016 Mar;34(3):312-9
pubmed: 26878319
Biomater Sci. 2021 Feb 7;9(3):535-573
pubmed: 33185203
Bioact Mater. 2022 Mar 03;16:66-81
pubmed: 35386331
Biotechnol Adv. 2016 Jul-Aug;34(4):422-434
pubmed: 26724184
Mater Sci Eng C Mater Biol Appl. 2019 Jun;99:103-111
pubmed: 30889635
J Orthop Res. 2017 Oct;35(10):2089-2097
pubmed: 28621834
BMJ. 2004 Aug 7;329(7461):304-5
pubmed: 15297323
Biomaterials. 2015 Dec;73:254-71
pubmed: 26414409
JAMA. 2018 Dec 25;320(24):2564-2579
pubmed: 30575881
Osteoarthritis Cartilage. 2022 Dec;30(12):1547-1560
pubmed: 36150678
Am J Sports Med. 2021 Jan;49(1):249-260
pubmed: 32302218
Adv Healthc Mater. 2020 Dec;9(24):e2001472
pubmed: 33103365
Small. 2019 Jun;15(24):e1805530
pubmed: 31012262
ACS Nano. 2014 Dec 23;8(12):12280-91
pubmed: 25415768
Expert Opin Biol Ther. 2016 Dec;16(12):1529-1540
pubmed: 27562879
J Biol Eng. 2015 Mar 01;9:4
pubmed: 25866560
Biomacromolecules. 2016 Jun 13;17(6):2137-2147
pubmed: 27171342
Acta Biomater. 2018 Jan;65:1-20
pubmed: 29128537
J Mater Sci Mater Med. 2019 Jan 28;30(2):20
pubmed: 30689057
ACS Appl Mater Interfaces. 2019 Mar 20;11(11):10559-10566
pubmed: 30790524
Med Biol Eng Comput. 2020 Aug;58(8):1681-1693
pubmed: 32458385
Front Bioeng Biotechnol. 2021 Sep 29;9:746564
pubmed: 34660559
Tissue Eng Part A. 2017 Jun;23(11-12):515-521
pubmed: 28351222
Bone. 2012 Aug;51(2):249-57
pubmed: 22387238
Cells. 2020 Dec 22;10(1):
pubmed: 33374921
J Mech Behav Biomed Mater. 2019 Jul;95:76-88
pubmed: 30954917
Biofabrication. 2019 Sep 10;11(4):042001
pubmed: 31315105
J Mater Sci Mater Med. 2019 Mar 6;30(3):32
pubmed: 30840132
Adv Mater. 2021 Feb;33(5):e2004776
pubmed: 33326131
Cell Mol Bioeng. 2018 May 21;11(4):219-240
pubmed: 31719887
Acta Biomater. 2020 Jan 1;101:26-42
pubmed: 31672585
Mater Sci Eng C Mater Biol Appl. 2020 Jun;111:110835
pubmed: 32279734
Chem Rev. 2020 Oct 14;120(19):10744-10792
pubmed: 32469510
Expert Opin Investig Drugs. 2017 Mar;26(3):375-380
pubmed: 28092725
J Funct Biomater. 2022 Aug 12;13(3):
pubmed: 35997456
Biofabrication. 2022 May 13;14(3):
pubmed: 35483326
Int J Biol Macromol. 2018 Feb;107(Pt A):261-275
pubmed: 28870749
Theranostics. 2019 Apr 13;9(9):2439-2459
pubmed: 31131046
Stem Cells Int. 2018 Feb 20;2018:6594841
pubmed: 29535776
J Magn Reson Imaging. 2022 Aug;56(2):570-578
pubmed: 34994024
Adv Mater. 2023 Jun;35(26):e2208852
pubmed: 36633376
Biofabrication. 2018 Aug 21;10(4):045006
pubmed: 30088479
ACS Appl Mater Interfaces. 2023 Feb 13;:
pubmed: 36779653
Theranostics. 2019 Sep 21;9(23):6949-6961
pubmed: 31660079
Biotechnol Lett. 2016 Feb;38(2):203-11
pubmed: 26466597
Tissue Eng Regen Med. 2021 Jun;18(3):343-353
pubmed: 33864626
Biomaterials. 2021 Dec;279:121216
pubmed: 34739982
Int J Biol Macromol. 2023 Jan 1;224:1152-1165
pubmed: 36346262
Biomed Mater. 2022 Dec 08;18(1):
pubmed: 36395510
ACS Appl Bio Mater. 2021 May 17;4(5):4049-4070
pubmed: 35006822
Lancet. 2011 Jun 18;377(9783):2115-26
pubmed: 21684382
Biomaterials. 2020 Jan;226:119536
pubmed: 31648135
Eur J Orthop Surg Traumatol. 2020 Jan;30(1):123-131
pubmed: 31420732
Biofabrication. 2021 Dec 31;14(1):
pubmed: 34905737
AAPS PharmSciTech. 2020 Feb 24;21(3):95
pubmed: 32096106
Theranostics. 2021 Jul 6;11(16):7948-7969
pubmed: 34335973
Cartilage. 2021 Dec;13(2_suppl):1755S-1769S
pubmed: 32070108
Pharmaceutics. 2022 Jul 29;14(8):
pubmed: 36015207
Nat Rev Rheumatol. 2011 Jan;7(1):33-42
pubmed: 21119608
Mater Sci Eng C Mater Biol Appl. 2019 Mar;96:176-182
pubmed: 30606523
Mater Sci Eng C Mater Biol Appl. 2017 Sep 1;78:452-456
pubmed: 28576008
Am J Phys Med Rehabil. 2006 Nov;85(11 Suppl):S51-65; quiz S66-8
pubmed: 17079979
Cell Tissue Bank. 2022 Sep;23(3):417-440
pubmed: 35000046
Bioact Mater. 2022 Jan 25;17:81-108
pubmed: 35386447
Bioengineering (Basel). 2021 Oct 18;8(10):
pubmed: 34677217
Adv Healthc Mater. 2022 Oct;11(19):e2200251
pubmed: 35857383
Sci Adv. 2022 Apr;8(13):eabk0011
pubmed: 35353555
Nat Rev Dis Primers. 2016 Oct 13;2:16072
pubmed: 27734845
Nanotheranostics. 2023 Mar 5;7(3):236-257
pubmed: 37064613
J Nanobiotechnology. 2021 Oct 26;19(1):343
pubmed: 34702302
J Transl Med. 2016 Sep 20;14:271
pubmed: 27645770